Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A1 | P22736 | 1/20 | 0.61 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.61 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.61 |
| ▸ | WDR5 | P61964 | 1/20 | 0.57 |
| ▸ | IDO1 | P14902 | 1/20 | 0.57 |
| ▸ | LDHA | P00338 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | NGLY1 | Q96IV0 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29599514 | 1.00 | NR4A1 (0.61) | NR4A1NR4A2NR4A3WDR5IDO1 | |
| Hydrochloric Acid SCHEMBL21173945 | 0.98 | NR4A1 (0.59) | NR4A1NR4A2NR4A3WDR5IDO1 | |
| Hydrochloric Acid SCHEMBL28890343 | 0.98 | NR4A1 (0.59) | NR4A1NR4A2NR4A3WDR5IDO1 | |
| SCHEMBL6051302 | 0.90 | ACMSD (0.54) | NR4A1NR4A2NR4A3WDR5IDO1 | |
| SCHEMBL4181791 | 0.88 | NR4A1 (0.50) | NR4A1NR4A2NR4A3WDR5IDO1 | |
| SCHEMBL1065938 | 0.87 | HMGB1 (0.49) | NR4A1NR4A2NR4A3WDR5IDO1 | |
| SCHEMBL9193278 | 0.87 | CYP1A2 (0.49) | NR4A1NR4A2NR4A3WDR5IDO1 | |
| SCHEMBL13173721 | 0.85 | NR4A1 (0.47) | NR4A1NR4A2NR4A3WDR5IDO1 | |
| SCHEMBL29405887 | 0.85 | ALDH1A1 (0.69) | NR4A1NR4A2NR4A3WDR5IDO1 | |
| SCHEMBL123193 | 0.85 | ALDH1A1 (0.69) | NR4A1NR4A2NR4A3WDR5IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101516861-B | Method for producing bisbenzoxazoles | CLARIANT INT LTD | 2014-07-16 | — | — | CN | claimed |
| US-8067612-B2 | Method for producing bisbenzoxazoles | CLARIANT FINANCE (BVI) LIMITED (VG) | 2011-11-29 | — | — | US | claimed |
| US-20100076040-A1 | Method For Producing Bisbenzoxazoles | Clariant Finance Wickhams Cay (VG) | 2010-03-25 | — | — | US | claimed |
| CN-101516861-A | Method for producing bisbenzoxazoles | CLARIANT INT LTD (VG) | 2009-08-26 | — | — | CN | claimed |
| EP-4749728-A1 | PROTON CONDUCTOR, METHOD FOR PRODUCING SAME, AND ELECTROCHEMICAL CELL | Mitsui Kinzoku Company, Limited (JP) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026100662-A1 | LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-20250348000-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2025-11-13 | — | — | US | disclosed |
| EP-4640738-A1 | METHOD FOR PRODUCING POLYESTER RESIN, AND POLYESTER RESIN | Toray Industries, Inc. (JP) | 2025-10-29 | — | — | EP | disclosed |
| US-20250155813-A1 | PROTECTIVE FILM FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2025-05-15 | — | — | US | disclosed |
| WO-2025100204-A1 | POLYESTER RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | 東レ株式会社 | 2025-05-15 | — | — | WO | disclosed |
| EP-4545584-A1 | RECYCLED MONOMER, RECYCLED MONOMER PRODUCTION METHOD, AND RECYCLED MONOMER PRODUCTION DEVICE | Toray Industries, Inc. (JP) | 2025-04-30 | — | — | EP | disclosed |
| WO-2025033304-A1 | METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNMENT FILM, AND METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-02-13 | — | — | WO | disclosed |
| EP-0004973-B1 | THERMOPLASTIC MOULDING COMPOSITIONS ON THE BASIS OF POLYACETALS | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-07-14 | — | — | EP | disclosed |
| US-4277577-A | IMPROVED IMPACT STRENGTH | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-07-07 | — | — | US | disclosed |
| US-4249022-A | Process for the manufacture of 1,4-disubstituted bicyclic or tricyclic compounds and new 1,4-disubstituted bicyclic compounds | CIBA-GEIGY CORPORATION (US) | 1981-02-03 | — | — | US | disclosed |
| EP-0004973-A1 | Thermoplastic moulding compositions on the basis of polyacetals | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-10-31 | — | — | EP | disclosed |
| US-4169867-A | MOLDING COMPOSITIONS BASED ON OXYMETHYLENE POLYMERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-10-02 | — | — | US | disclosed |
| US-4154754-A | 1,4-Dicyanonaphthalenes | CIBA-GEIGY CORPORATION (US) | 1979-05-15 | — | — | US | disclosed |
| US-4048212-A | Process for the manufacture of 1,4-dicyanonaphthalenes | CIBA-GEIGY CORPORATION (US) | 1977-09-13 | — | — | US | disclosed |
| US-4011261-A | PROCESS FOR THE MANUFACTURE OF 1,4-DISUBSTITUTED BICYCLIC OR TRICYCLIC COMPOUNDS AND NEW 1,4-DISUBSTITUTED BICYCLIC COMPOUNDS | CIBA-GEIGY CORPORATION (US) | 1977-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076040-A1 | Method For Producing Bisbenzoxazoles | DDO, DAO, AADAC | NR4A1 4094/4885NR4A2 3953/4885NR4A3 3693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.